Cargando…
Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis
While dysplastic liver nodules in cirrhosis are pre-malignant, little is known about the predictors of hepatocarcinogenesis of these lesions. This was a retrospective observational study of subjects with cirrhosis who had at least one hypervascular, non-malignant intrahepatic nodule on imaging while...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545953/ https://www.ncbi.nlm.nih.gov/pubmed/34697374 http://dx.doi.org/10.1038/s41598-021-00474-5 |
_version_ | 1784590095669526528 |
---|---|
author | Gazelakis, Kathryn Majeed, Ammar Kemp, William Di Muzio, Bruno Gerstenmaier, Jan Cheung, Wa Roberts, Stuart K. |
author_facet | Gazelakis, Kathryn Majeed, Ammar Kemp, William Di Muzio, Bruno Gerstenmaier, Jan Cheung, Wa Roberts, Stuart K. |
author_sort | Gazelakis, Kathryn |
collection | PubMed |
description | While dysplastic liver nodules in cirrhosis are pre-malignant, little is known about the predictors of hepatocarcinogenesis of these lesions. This was a retrospective observational study of subjects with cirrhosis who had at least one hypervascular, non-malignant intrahepatic nodule on imaging while undergoing outpatient management by a tertiary hepatology referral centre between Jan 2009 and Jan 2019. Clinical and biochemical parameters were collected. The primary endpoint was transformation to hepatocellular carcinoma (HCC) as determined by Liver Imaging Reporting and Data System. During the study period, 163 non-malignant hypervascular nodules were identified in 77 patients; 147 had at least 6 months of follow up imaging and 16 received upfront radiofrequency ablation upon detection. During a median follow up of 38.5 months (IQR 16.5–74.5), 25 (17%) of the 147 hypervascular nodules being monitored transformed to HCC. On multivariate analysis, Child–Pugh grade was found to be the only independent predictor of nodule transformation into HCC (p = 0.02). Those with Child–Pugh B and C liver disease had a 10.1 (95% CI 1.22–83.8; p = 0.03) and 32.6-fold (95% CI 2.3–467; p = 0.01) increased risk respectively for HCC transformation compared to Child–Pugh A subjects. This large, single centre study demonstrates that around 20% of dysplastic nodules in cirrhotic patients undergo hepatocarcinogenesis during follow up, and that Child Pugh grade is the only independent predictor of transformation to HCC. Additional prospective studies are warranted to better understand the risk profile of these nodules, and how best they should be managed. |
format | Online Article Text |
id | pubmed-8545953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85459532021-10-27 Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis Gazelakis, Kathryn Majeed, Ammar Kemp, William Di Muzio, Bruno Gerstenmaier, Jan Cheung, Wa Roberts, Stuart K. Sci Rep Article While dysplastic liver nodules in cirrhosis are pre-malignant, little is known about the predictors of hepatocarcinogenesis of these lesions. This was a retrospective observational study of subjects with cirrhosis who had at least one hypervascular, non-malignant intrahepatic nodule on imaging while undergoing outpatient management by a tertiary hepatology referral centre between Jan 2009 and Jan 2019. Clinical and biochemical parameters were collected. The primary endpoint was transformation to hepatocellular carcinoma (HCC) as determined by Liver Imaging Reporting and Data System. During the study period, 163 non-malignant hypervascular nodules were identified in 77 patients; 147 had at least 6 months of follow up imaging and 16 received upfront radiofrequency ablation upon detection. During a median follow up of 38.5 months (IQR 16.5–74.5), 25 (17%) of the 147 hypervascular nodules being monitored transformed to HCC. On multivariate analysis, Child–Pugh grade was found to be the only independent predictor of nodule transformation into HCC (p = 0.02). Those with Child–Pugh B and C liver disease had a 10.1 (95% CI 1.22–83.8; p = 0.03) and 32.6-fold (95% CI 2.3–467; p = 0.01) increased risk respectively for HCC transformation compared to Child–Pugh A subjects. This large, single centre study demonstrates that around 20% of dysplastic nodules in cirrhotic patients undergo hepatocarcinogenesis during follow up, and that Child Pugh grade is the only independent predictor of transformation to HCC. Additional prospective studies are warranted to better understand the risk profile of these nodules, and how best they should be managed. Nature Publishing Group UK 2021-10-25 /pmc/articles/PMC8545953/ /pubmed/34697374 http://dx.doi.org/10.1038/s41598-021-00474-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Gazelakis, Kathryn Majeed, Ammar Kemp, William Di Muzio, Bruno Gerstenmaier, Jan Cheung, Wa Roberts, Stuart K. Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis |
title | Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis |
title_full | Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis |
title_fullStr | Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis |
title_full_unstemmed | Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis |
title_short | Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis |
title_sort | liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545953/ https://www.ncbi.nlm.nih.gov/pubmed/34697374 http://dx.doi.org/10.1038/s41598-021-00474-5 |
work_keys_str_mv | AT gazelakiskathryn liverdiseaseseveritypredictscarcinogenesisofdysplasticlivernodulesincirrhosis AT majeedammar liverdiseaseseveritypredictscarcinogenesisofdysplasticlivernodulesincirrhosis AT kempwilliam liverdiseaseseveritypredictscarcinogenesisofdysplasticlivernodulesincirrhosis AT dimuziobruno liverdiseaseseveritypredictscarcinogenesisofdysplasticlivernodulesincirrhosis AT gerstenmaierjan liverdiseaseseveritypredictscarcinogenesisofdysplasticlivernodulesincirrhosis AT cheungwa liverdiseaseseveritypredictscarcinogenesisofdysplasticlivernodulesincirrhosis AT robertsstuartk liverdiseaseseveritypredictscarcinogenesisofdysplasticlivernodulesincirrhosis |